Glycomet 500 vs Jan Aushadhi Metformin 500: Bioequivalence & 90% Cost Difference
Detailed clinical comparison of Glycomet 500 (USV) vs PMBJP generic Metformin 500mg: NABL chemical purity, blood sugar control, and saving 90% annually.
Glycomet 500 (USV Ltd) is India's most popular branded Metformin, while Jan Aushadhi Metformin 500mg is the government-certified generic equivalent. Both contain identical Metformin Hydrochloride 500mg, manufactured to Indian Pharmacopoeia standards. A diabetic taking 2 tablets daily spends ~₹800/year on Glycomet vs ~₹80/year at Jan Aushadhi—saving over 90% with identical blood sugar control.
1. Chemical Identity & Pharmacopoeia Verification
Both Glycomet and generic Metformin contain 500mg Metformin HCl with identical dissolution profiles, chemical assay purity (98-102%), and pharmacokinetic bioavailability. Both activate cellular AMPK pathways to lower fasting and post-meal glucose.
2. Why the 90% Price Gap Exists
Branded medicines invest heavily in field medical representatives, marketing conferences, and physician promotional incentives. PMBJP generic medicines are procured in massive central tenders directly from WHO-GMP manufacturers without marketing overhead.
3. Real-World HbA1c Equivalence
Clinical trials across Indian tertiary hospitals demonstrate that patients switching from branded Glycomet to certified generic Metformin experience zero deterioration in HbA1c control.
Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison
Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.
| Brand Name | Leading Manufacturer | Active Salt Formulation (IP) | Branded MRP | Jan Aushadhi Price | Savings % |
|---|---|---|---|---|---|
| Augmentin 625 Duo | GlaxoSmithKline Pharmaceuticals | Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP | ₹220.00 | ₹58.00 | 74% |
| Dolo 650 | Micro Labs Ltd | Paracetamol (Acetaminophen) 650mg IP | ₹34.00 | ₹5.50 | 84% |
| Pantocid 40 | Sun Pharmaceutical Industries | Pantoprazole Sodium 40mg IP (Gastro-resistant) | ₹155.00 | ₹8.00 | 95% |
| Azithral 500 | Alembic Pharmaceuticals | Azithromycin Dihydrate 500mg IP | ₹132.00 | ₹24.00 | 82% |
| Glycomet 500 | USV Private Limited | Metformin Hydrochloride 500mg IP | ₹24.00 | ₹4.50 | 81% |
| Shelcal 500 | Torrent Pharmaceuticals | Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP | ₹134.00 | ₹16.00 | 88% |
| Telma 40 | Glenmark Pharmaceuticals | Telmisartan 40mg IP | ₹92.00 | ₹7.50 | 92% |
| Montair-LC | Cipla Ltd | Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP | ₹210.00 | ₹18.00 | 91% |
| Combined 8-Drug Essential Therapy Basket Total: | ₹1,001.00 | ₹141.00 | 85.9% Net Savings | ||
Frequently Asked Questions (Clinical & Regulatory)
Q1: Can I switch from Glycomet to Jan Aushadhi Metformin without changing dosage?
Yes, you switch 1:1 at the exact same milligram dose (e.g. 500mg for 500mg), taken with your regular meals.
Q2: Does generic Metformin cause more loose motions than Glycomet?
No, gastrointestinal tolerance depends on the active metformin salt and whether you take it with food, which is identical across both.
Q3: How does the CDSCO define bioequivalence when comparing two pharmaceutical formulations?
Bioequivalence is confirmed when two pharmaceutical products contain identical active therapeutic moieties and show no statistically significant difference in Cmax and AUC under single-dose fasting and fed pharmacokinetic studies within the 80% to 125% confidence interval.
Q4: When comparing two drugs in the same clinical class, what determines superior therapeutic choice?
Therapeutic selection depends on receptor selectivity, onset speed, elimination half-life, clearance pathway (hepatic CYP450 vs renal excretion), drug interaction liability, and clinical trial evidence regarding organ-specific outcomes.
Q5: Can patients interchange two bioequivalent branded formulations without loss of efficacy?
Yes. Formulations produced under Schedule M Good Manufacturing Practices containing identical active pharmaceutical salts and dissolution profiles can be interchanged safely under pharmacist guidance.
This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.
Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.